Page last updated: 2024-12-04

2,3-butylene glycol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth

Description

2,3-butylene glycol: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

butane-2,3-diol : A butanediol in which hydroxylation is at C-2 and C-3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID262
CHEMBL ID2312529
CHEBI ID62064
MeSH IDM0088067

Synonyms (77)

Synonym
513-85-9
45427zb5ij ,
unii-45427zb5ij
ec 208-173-6
4-01-00-02524 (beilstein handbook reference)
AKOS009031391
2,3-butanediol, (r*,r*)-(.+/-.)-
butane-2,3-diol
levo-butane-2,3-diol
nsc249246
35007-63-7
sym-dimethylethylene glycol
dimethylethylene glycol
pseudobutylene glycol
hsdb 1505
ccris 5501
brn 0969165
einecs 208-173-6
2,3-dihydroxybutane
dimethylene glycol
inchi=1/c4h10o2/c1-3(5)4(2)6/h3-6h,1-2h
2,3-butanediol
2,3-butylene glycol
2,3-butanediol, 98%
B0681
FT-0656644
NCGC00248169-01
CHEBI:62064 ,
tox21_300789
dtxsid8041321 ,
dtxcid6021321
NCGC00254693-01
cas-513-85-9
(2s,3s)-(+)2,3-butanediol
FT-0605350
FT-0604653
butan-2,3-diol
CHEMBL2312529
dimethyl ethylene glycol
butane 2,3-diol
2,3-dihydroxy-butane
2,3-butane diol
dimethyl ethyleneglycol
2,3-dihydroxy butane
dl-2,3-butandiol
2,3-butanediol (dl)
FT-0696715
2d-pharmalyte(9ci)
123513-85-9
347841-77-4
344750-80-7
2,3-butane-d8-diol
mfcd00004523
d-2,3-butane diol
2,3-butandiol
2,3-butanodiol
2,3-butanediol, vetec(tm) reagent grade, 98%
F0001-1337
FT-0720882
HY-128387
SY057405
SY047189
F14836
Q209157
methyl5-acetyl-3-ethylisoxazole-4-carboxylate
a 2,3-butylene glycol
a 2,3-butanediol
a butane-2,3-diol
CS-0099502
2.3-butanediol
S6040
(2r,3r)-(-)2,3-butanediol
SB44226
SB44692
EN300-19321
nistc6982258
Z104473532

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
" A sub-category of SIMs, referred to in the literature as synthetic ice blockers (SIBs), are compounds that interact directly with ice nuclei or crystals to modify their structure and/or rate of growth."( Thermal expansion of the cryoprotectant cocktail DP6 combined with synthetic ice modulators in presence and absence of biological tissues.
Eisenberg, DP; Rabin, Y; Taylor, MJ, 2012
)
0.38

Bioavailability

ExcerptReferenceRelevance
" Eighteen organic solvents were screened to determine their biocompatibility, and bioavailability for their effects on Klebsiella pneumoniae growth."( In situ recovery of 2,3-butanediol from fermentation by liquid-liquid extraction.
Anvari, M; Khayati, G; Pahlavanzadeh, H; Vasheghani-Farahani, E, 2009
)
0.35

Dosage Studied

ExcerptRelevanceReference
" On the other hand, high levels of acetoin were found out in portal plasma for early period after dosing of LAPC."( [Metabolism of lenampicillin hydrochloride. II. Metabolism of promoiety].
Aoyama, T; Awata, N; Noumi, K; Takaki, A; Uemura, Y, 1985
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (1 Product(s))

Product Categories

Product CategoryProducts
Beauty & Personal Care1

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Cleo+Coco Prebiotic Deodorant Spray - Cucumber Mint -- 3.38 fl ozCleo+CocoBeauty & Personal Care2,3-butanediol, glycerin, hexylene glycol, levulinic acid2024-11-29 10:47:42

Drug Classes (3)

ClassDescription
butanediolA member of the class of butanediols that is butane in which two of the hydrogens have been replaced by hydroxy groups.
glycolA diol in which the two hydroxy groups are on different carbon atoms, usually but not necessarily adjacent.
secondary alcoholA secondary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has two other carbon atoms attached to it.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoid X nuclear receptor alphaHomo sapiens (human)Potency15.47170.000817.505159.3239AID1159527; AID1159531
estrogen nuclear receptor alphaHomo sapiens (human)Potency77.49220.000229.305416,493.5996AID743079
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency54.86020.000323.4451159.6830AID743066
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1134606Et2O-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID1134605Oil-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID721517Displacement of 2OG from catalytic domain of PHD2 (181 to 426) (unknown origin) Zn2 expressed in Escherichia coli at 150 uM2013Journal of medicinal chemistry, Jan-24, Volume: 56, Issue:2
Reporter ligand NMR screening method for 2-oxoglutarate oxygenase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (521)

TimeframeStudies, This Drug (%)All Drugs %
pre-199072 (13.82)18.7374
1990's42 (8.06)18.2507
2000's49 (9.40)29.6817
2010's297 (57.01)24.3611
2020's61 (11.71)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.37%)5.53%
Reviews27 (5.02%)6.00%
Case Studies1 (0.19%)4.05%
Observational0 (0.00%)0.25%
Other508 (94.42%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]